DOI: https://doi.org/10.32652/nos.v0i3.167142

Фармакологическая и нутрициологическая поддержка функции опорно-двигательного аппарата квалифицированных спортсменов

Лариса Гунина, Александр Дмитриев, Ольга Юшковская

Аннотация


Цель. Сформировать представление о современной системе патогенетически обоснованного использования фармакологических препаратов и диетических добавок для профилактики и лечения заболеваний суставов у квалифицированных спортсменов. Методы. Анализ и синтетическое обобщение научно-методической литературы, а также данных сети Интернет по изучаемому вопросу. Результаты. Приведены данные о частоте распространения и причинах возникновения поражения суставного аппарата у спортсменов высокой квалификации. Описаны группы фармакологических и нутрициологических средств, применяемых в мировой практике для профилактики и лечения подобных заболеваний при занятиях спортом. Сделан акцент на неверности переноса методологии лечении пациентов с ревматоидным артритом на систему профилактики и лечения спортсменов при поражении суставов, где развитие данной патологии опосредовано прежде всего травматическим фактором. Описаны возможные осложнения при использовании наиболее часто применяемых в подобных ситуациях нестероидных противовоспалительных средствах, дана их современная классификация. Достаточно детально освещены вспомогательные средства профилактики и лечения поражений суставного аппарата с применением пищевых добавок, приведены данные по их эффективности с точки зрения доказательной медицины. Заключение. Подход спортивного врача к профилактике и лечению патологии суставного аппарата у спортсменов в плане применения всего спектра необходимых лекарственных средств и пищевых добавок должен быть комплексным, а также должен учитывать специфику вида спорта, особенности антидопингового законодательства в сфере системного, местного и внутрисуставного применения глюкокортикоидов.


Ключевые слова


спорт высших достижений; заболевания связочно-суставного аппарата; фармакологические препараты; пищевые добавки

Полный текст:

PDF (English) PDF

Литература


Дмитриев АВ, Гунина ЛМ. Основы спортивной нутрициологии [Foundations of sports’ nutriciology]:монография. СПб.: Идеал Фарма Пептид; 2018. 560 с.

Дмитриев АВ, Калинчев АА. Витамин D: роль в спорте и спортивной медицине (обзор литературы) [Vitamin D: the role in sports and sports medicine (literature review)]. Наука в олимпийском спорте. 2017;(1):56–74.

Дмитриев АВ, Калинчев АА. Фармаконутриенты в спортивной медицине [Pharmaconutrients in sports medicine]. 2-ое изд. Москва: Изд-во «Бином»; 2017. 302 с.

Калмин О, Бочкарева И, Галкина Т. Артрология: учебное пособие [Arthrology: study guide].Пенза: ПГМУ; 2016. 64 с.

Красина ИБ, Бродовая ЕВ. Современные исследования спортивного питания [Modern studies on sports nutrition]. Современные проблемы науки и образования [Internet]. 2017;5. Available from: https://www.science-education.ru/ru/article/view?id=26809.

Кулиненков ОС. Фармакологическая помощь спортсмену: коррекция фак-торов, лимитирующих спортивный результат [Pharmacological aid for an athlete: Correction of factors limiting sports performance].Москва: Советский спорт; 2007. 139 с.

Насонова ВА. Роль циклооксигеназы-2 (COG-2) в этиологии боли [Role of cyclooxygenase-2 (COG-2) in the etiology of pain]. Терапевтический архив. 2001;73(5):56–7.

Петерсон Л, Ренстрём П. Травмы в спорте [Injuries in sport]. Москва: Физкультура и спорт; 1981. 272 с.

Ренстрём ПАФХ, Левенец В. Спортивные травмы. Клиническая практика преду -преждения и лечения [Sports injuries. Clinical practice of prevention and treatment]. Киев: Олимпийская литература; 2002. 472 с.

Родичкин ПВ, Шаламанов НС. Клиническая фармакология хондропротекторов [Clinical pharmacology of chondroprotectors]. Обзоры по клинической фармакологии и лекар-ственной терапии. 2012;10(3):18–27.

Троегубова НА, Рылова НВ, Самойлов АС. Микронутриенты в питании спортсме-нов [Micronutrients in the diet of athletes]. Практическая медицина. 2014;1(77):46–9.

Фармакология спорта [Pharmacology of sport]. Олейник СА, Гунина ЛМ, Сейфулла РД, редакторы. Киев: Олимпийская литература; 2010. 639 c.

Abbey EL, Wright CJ, Kirkpatrick CM. Nutrition practices and knowledge among NCAA Division III football players.J Intern Soc Sports Nutr.2017;14:13. DOI: 10.1186/s12970-017-0170-2.

Aggarwal BB, Prasad S, Reuter S, et al. Identifi cation of novel anti-infl ammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.Curr Drug Targets. 2011;12(11):1595–653.

Aguirre A, Quintana EG, Fenaux M, et al. Eff ects of 50 Days Eggshell Membrane Ovomet® Supplementation on Biomechanics Parameters and Subjective Pain Perception Among Crossfi t Athletes. A Preliminary Study. J. Trauma Treat. 2017а;6:2.

Aguirre A, Quintana EG, Fenaux M, еt al. Eff ects of 50 Days Ovomet® Supplementation on Biomechanical Parameters and Subjective Pain Perception among Old Institutionalized Patients. A Preliminary Study.J Osteopor Phys Act. 2017b;5:1. DOI: 10.4172/2329–9509.1000198.

Amalraj A, Jude S, Varma K, et al. Preparation of a novel bioavailable curcuminoid formulation (Cureit™) using Polar-Nonpolar-Sandwich (PNS) technology and its characterization and applications. Mater. Sci. Eng. 2017;75:359–67.

Bannuru RR, Schmid CH, Kent DM, et al. Comparative eff ectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162(1):46–54. DOI: 10.7326/M14-1231.

Bannuru RR, Vaysbrot EE, Sullivan MC, McAlindon TE. Relative effi cacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and metaanalysis. Semin Arthritis Rheum.2014;43(5):593–9. DOI: 10.1016/j.semarthrit.2013.10.002.

Bellamy N, Campbell J, Robinson V. et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;(2):CD005328.

Bruyère O, Cooper C, Pelletier JP, et al. A consensus statement on the European Society for Clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum.2016;45(Suppl 4):S3–S11. DOI: 10.1016/j.semarthrit.2015.11.010.

Bruynzeel AM, Abou El Hassan MA, Schalkwijk C, Berkhof J, Bast A, Niessen HW, van der Vijgh WJ. Anti-infl ammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice. Br Cancer. 2007;96(6):937–43. DOI: 10.1038/sj.bjc.6603640.

Chen YF, Jobanputra P, Barton P, et al. Cyclooxygenase-2 selective non-steroidal antiinfl ammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess. 2008;12(11):1–278.

Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.N Engl J Med. 2006;354(8):795–808.

Close GL, Hamilton DL, Philp A, et al. New strategies in sport nutrition to increase exercise performance. Free Radic. Biol. Med. 2016;98:144–58. DOI: 10.1016/j.freeradbiomed.2016.01.016.

Coaccioli S. Ketoprofen 2.5% gel: a clinical overview.Eur Rev Med Pharmacol Sci. 2011;15(8):943–9.

Conaghan PG, Dickson J, Bolten W, Cevc G, Rother M. A multicentre, randomized, placebo- and active-controlled trial comparing the effi cacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology(Oxford). 2013;52(7):1303–12. DOI: 10.1093/rheumatology/ket133.

Drawer S, Fuller CW. Propensity for osteoarthritis and lower limb joint pain in retired professional soccer players.Br J Sports Med. 2001;35(6):402–8.

Driban JB, Hootman JM, Sitler MR, et al. Is Participation in Certain Sports Associated With Knee Osteoarthritis? A Systematic Review. J Athl Train. 2017;52(6):497–506. DOI: 10.4085/1062-6050-50.2.08.

Fries JF, Williams CA, Bloch D. The relative toxicity of non-steroidal anti-infl ammatory drugs. Arthritis and Rheumatism. 2001;44(11):1353–60.

Gallo J. Nutraceuticals in therapy of knee osteoarthritis: orthopaedic view. Vnitr Lek.2018;64(2):191–6.

Garg Y, Singh J, Sohal HS, et al. Comparison of Clinical Eff ectiveness and Safety of Newer Nonsteroidal Anti-infl ammatory Drugs in Patients of Osteoarthritis of Knee Joint: A Randomized, Prospective, Open-label Parallel-group Study. Indian J Pharmacol. 2017;49(5):383–9. DOI: 10.4103/ijp.IJP_245_16.

Gerbeth K, Hüsch J, Fricker G, et al. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoterapia. 2013;84:99–106. DOI: 10.1016/j.fi tote.2012.10.009.

Hajja G, Bahlouli A. Medicinal Plants in the Prevention and Treatment of Rheumatoid Arthritis. MOJ Bioequiv Availab. 2018;5(1):00084. DOI: 10.15406/mojbb.2018.05.00084.

Hatayama T, Nagano M, Yamaguchi N, et al. The eff ect of a supplement on knee pain and discomfort evaluated by visual analogue scale (VAS): a randomized, double-blind, placebocontrolled study. Kenkoshien. 2008;10:13–7.

Horváth VJ, Tabák GÁ, Szabó G, et al. [Cardiovascular side eff ects of non-steroidal antiinfl ammatory drugs in the light of recent recommendations. Diclofenac is not more dangerous]. Orv Hetil. 2015;156(13):516–20. DOI: 10.1556/OH.2015.30120.

Intekhab-Alam NY, White OB, Getting SJ, et al. Urocortin protects chondrocytes from NO-induced apoptosis: a future therapy for osteoarthritis? Cell Death Dis. 2013;4:e717. DOI: 10.1038/cddis.2013.231.

Iozzo RV, Schaefer L. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol.2015;42:11–55. DOI: 10.1016/j.matbio.2015.02.003.

Iwaso H, Sato T. Examination of the effi cacy and safety of oral administration of Hyabest® (J) highly-pure hyaluronic acid for knee joint pain. J Jpn Soc Clin Sports Med.2009;58:566–72.

Jensen GS, Attridge VL, Lenninger MR, Benson KF. Oral intake of a liquid high-molecular weight hyaluronan associated with relief of chronic pain and reduced use of pain medication: results of a randomized, placebocontrolled double-blind pilot study. J Med Food.2015a;18(1):95–101. DOI: 10.1089/jmf.2013.0174.

Jensen GS, Lenninger MR, Beaman JL, et al. Support of Joint Function, Range of Motion, and Physical Activity Levels by Consumption of a Water-Soluble Egg Membrane Hydrolyzate. J Med Food. 2015b;18(9):1042–8. DOI: 10.1089/jmf.2015.0041.

Kalman DS, Hewlings SJ. The Eff ects of Morus alba and Acacia catechu on Quality of Life and Overall Function in Adults with Osteoarthritis of the Knee. Hindawi J Nutr Metab.2017;2017:4893104. DOI: 10.1155/2017/4893104.

Kawabata A. Prostaglandin E2 and pain--an update. Biol Pharm Bull.2011;34(8):1170–3.

Kean WF, Rainsford KD, Kean IR. Management of chronic musculoskeletal pain in the elderly: opinions on oral medication use. Infl ammopharmacology.2008;16(2):53–75. DOI: 10.1007/s10787-008-1623-7.

Kujala UM, Kaprio J, Sarna S. Osteoarthritis of weight bearing joints of lower limbs in former elite male athletes.Br Med J. 1994;308(6923):231–4.

Lahoti A, Kalra BS, Tekur U. Evaluation of the analgesic and anti-infl ammatory activity of fi xed dose combination: non-steroidal anti-infl ammatory drugs in experimental animals. Indian JDent Res. 2014;25(5):551–4. DOI: 10.4103/0970-9290.147071.

Lefèvre-Colau MM, Nguyen C, Haddad R, et al. Is physical activity, practiced as recommended for health benefi t, a risk factor for osteoarthritis? Ann Phys Rehabil Med. 2016;59(3):196–206. DOI: 10.1016/j.rehab.2016.02.007.

Liu X, Machado GC, Eyles JP, et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis.Br J Sports Med. 2018;52(3):167–75.

Mateos JL. Selective inhibitors of cyclooxygenase-2 (COX-2), celecoxib and parecoxib: a systematic review.Drugs Today(Barc). 2010;46(Suppl A):1–25.

Maughan RJ, Burke LM, Dvorak J, et al. (total 25 authors). IOC consensus statement: dietary supplements and the high-performance athlete.Br J Sports Med. 2018;52(7):439–55. DOI: 10.1136/bjsports-2018-099027.

Mazzuca SA, Brandt K. The therapeutic approaches of community based primary care practitioners to osteoarthritis of the hip in an elderly patient. J Rheumatology.1991;18(10):1593–600.

Moura MDG, Lopes LC, Biavatti MWl, et al. Brazilian oral herbal medication for osteoarthritis: a systematic review protocol.Systematic Reviews. 2016;5:86. DOI: 10.1186/s13643–016–0261–1.

Muraki S, Tanaka S, Yoshimura N. Epidemiology of knee osteoarthritis. OA Sports Medicine.2013;1(3):21.

Narsinghani T, Sharma R. Lead optimization on conventional non-steroidal anti-infl ammatory drugs: an approach to reduce gastrointestinal toxicity. Lead optimization on conventional non-steroidal anti-infl ammatory drugs: an approach to reduce gastrointestinal toxicity. Chem Biol Drug Des.2014;84(1):1–23. DOI: 10.1111/cbdd.12292.

Nelson FR, Zvirbulis RA, Zonca B, et al. The eff ects of an oral preparation containing hyaluronic acid (Oralvisc®) on obese knee osteoarthritis patients determined by pain, function, bradykinin, leptin, infl ammatory cytokines, and heavy water analyses. Rheumatol Int. 2015;35(1):43–52 DOI: 10.1007/s00296-014-3047-6.

Oe M, Tashiro T, Yoshida H, et al. Oral hyaluronan relieves knee pain: a review. Nutr J. 2016;15:11–20. DOI: 10.1186/s12937–016–0128–2.

Ozcamdalli M, Misir A, Kizkapan TB, et al. Comparison of Intra-articular Injection of Hyaluronic Acid and N-Acetyl Cysteine in the Treatment of Knee Osteoarthritis: A Pilot Study. Cartilage. 2017;8(4):384–90. DOI: 10.1177/1947603516675915.

Peanpadungrat P. Effi cacy and Safety of Fish Oil in Treatment of Knee Osteoarthritis. J Med Assoc Thai. 2015;98(Suppl 3):S110–4.

Rogoveanu OC, Streba CT, Vere CC, et al. Superior digestive tract side eff ects after prolonged treatment with NSAIDs in patients with osteoarthritis.J Med Life.2015;8(4):458–61.

Salvato KF, Santos JP, Pires-Oliveira DA. [Analysis of the infl uence of pharmacotherapy on the quality of life of seniors with osteoarthritis]. Rev Bras Reumatol. 2015;55(1):83–8. DOI: 10.1016/j.rbr.2014.08.006. [Article in Portuguese].

Saxon L, Finch C, Bass S. Sports participation, sports injuries and osteoarthritis: implications for prevention Sports participation, sports injuries and osteoarthritis: implications for prevention. Sports Med.1999;28(2):123–35.

Simoneti LF, Weckwerth GM, Dionísio TJ, et al. Effi cacy of Ketoprofen With or Without Omeprazole for Pain And Infl ammation Control After Third Molar Removal.Braz Den J. 2018; 29(2): 140–149. doi: 10.1590/0103-6440201802254.

Singh G, Ramey DR, Morfeld D, Fries JF. Comparative toxicity of non-steroidal antiinfl ammatory agents. Pharmacol Ther.1994;62(1–2):175–91. PMID: 7991642.

Stemkowski PL, Garcia-Caballero A, Gadotti VM, et al. Identifi cation of interleukin-1 beta as a key mediator in the upregulation of Cav3.2-USP5 interactions in the pain pathway. Mol Pain. 2017;13:1744806917724698. DOI: 10.1177/1744806917724698.

Tashiro T, Seino S, Sato T, et al. Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period. Sci World J.2012;2012:167928. DOI: 10.1100/2012/167928.

Ueno T, Yamada M, Sugita Y, Ogawa T. N-acetyl cysteine protects TMJ chondrocytes from oxidative stress. J Dent Res. 2011;90(3):353–9. DOI: 10.1177/0022034510388035.

Vannini F, Spalding T, Andriolo L, et al. Sport and early osteoarthritis: the role of sport in aetiology, progression and treatment of knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc.2016;24(6):1786–96. DOI: 10.1007/s00167–016–4090–5.

Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Salvo F, Nicotra F, Sturkenboom M, Perez-Gutthann S. Myocardial infarction and individual nonsteroidal antiinfl ammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf. 2013;22(6):559–70. DOI: 10.1002/pds.3437.

Varrassi G, Hanna M, Macheras G, et al. Multimodal analgesia in moderate-to-severe pain: a role for a new fi xed combination of dexketoprofen and tramadol. Curr Med Re Opin. 2017;33(6):1165–73. DOI: 10.1080/03007995.2017.1310092.

Wallace JL, Reuter B, Cicala C, et al. Novel nonsteroidal anti-infl ammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology.1994;107(1):173–9.

Zanjani TM, Sabetkasaei M, Karimian B, et al. The attenuation of pain behaviour and serum interleukin-6 concentration by nimesulide in a rat model of neuropathic pain. Scand J Pain. 2010;1(4):229–34. DOI: 10.1016/j.sjpain.2010.08.003.

Zhu XT, Chen L, Lin JH. Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossifi cation after total hip arthroplasty: A meta-analysis. Medicine(Baltimore). 2018;97(31):e11649. DOI: 10.1097/MD.0000000000011649.




Creative Commons License
Эта работа лицензирована Creative Commons Attribution-NonCommercial 4.0 International License.